Podcasts about surgical

With the increasing incidence of colorectal cancer in those less than 50 years of age, one must wonder how many patients present with a Stage IV diagnosis. Take a deep dive with us discussing the management of metastatic colorectal cancer by joining our team and guests, Drs. Cathy Eng, Michael D'Angelica, and Nina Sanford.Hosts: - Dr. Janet Alvarez - General Surgery Resident at New York Medical College/Metropolitan Hospital Center- Dr. Wini Zambare – General Surgery Resident at Weill Cornell Medical Center/New York Presbyterian- Dr. Philip Bauer, Assistant Professor of Surgery, Division of Colon and Rectal Surgery, The Ohio State University Wexner Medical Center, Arthur G. James Cancer Hospital-  Dr. J. Joshua Smith MD, PhD, Chair, Department of Colon and Rectal Surgery at MD Anderson Cancer Center Guest Speakers:- Dr. Michael D'Angelica MD, FACS – Hepatopancreatobiliary Surgery, Memorial Sloan Kettering Cancer Center, Enid A. Haupt Chair in Surgery, Vice Chair, Education- Dr. Cathy Eng MD, FACP - Division of Hematology and Oncology, Vanderbilt-Ingram Cancer Center, David H. Johnson Endowed Chair in Surgical and Medical Oncology, Professor of Medicine, Hematology and Oncology, VICC Associate Director for Strategic Relations and Research Partnerships, Executive Director, Young Adult Cancers Program - Dr. Nina Sanford, MD – Radiation Oncology, UT Southwestern Medical Center, Chief of Gastrointestinal Radiation Oncology Service, Associate Professor Learning Objectives:1.     Review the epidemiology, prognosis, and common metastatic patterns of metastatic colorectal cancer (mCRC).2.     Discuss the role of systemic chemotherapy and targeted therapies in the first- and subsequent-line treatment of mCRC, including the impact of molecular biomarkers such as MSI/MMR, RAS, BRAF, and HER2.3.     Evaluate the indications and timing of surgical and locoregional therapies for metastatic colorectal cancer, particularly in patients with liver-limited or oligometastatic disease.4.     Describe the multidisciplinary management of mCRC, including the roles of radiation therapy, systemic therapy sequencing, and palliative interventions to optimize outcomes and quality of life.References:Singh, M., Morris, V. K., Bandey, I. N., Hong, D. S. & Kopetz, S. Advancements in combining targeted therapy and immunotherapy for colorectal cancer. Trends Cancer 10, 598–609 (2024). PubMed Link: https://pubmed.ncbi.nlm.nih.gov/38821852/Napolitano, S. et al. BRAFV600E mutant metastatic colorectal cancer: Current advances in personalized treatment and future perspectives. Cancer Treat. Rev. 134, (2025). PubMed Link: https://pubmed.ncbi.nlm.nih.gov/40009904/Ciardiello, F. et al. Clinical management of metastatic colorectal cancer in the era of precision medicine. CA. Cancer J. Clin. 72, 372–401 (2022). PubMed Link: https://pubmed.ncbi.nlm.nih.gov/35472088/Kim, S. Y. & Kim, T. W. Current challenges in the implementation of precision oncology for the management of metastatic colorectal cancer. ESMO Open 5, e000634 (2020). PubMed Link: https://pubmed.ncbi.nlm.nih.gov/32188714/Biller, L. H. & Schrag, D. Diagnosis and Treatment of Metastatic Colorectal Cancer: A Review. JAMA 325, 669–685 (2021). PubMed Link: https://pubmed.ncbi.nlm.nih.gov/33591350/Smith, J. J. et al. Genomic stratification beyond Ras/B-Raf in colorectal liver metastasis patients treated with hepatic arterial infusion. Cancer Med. 8, 6538–6548 (2019). PubMed Link: https://pubmed.ncbi.nlm.nih.gov/31503397/Saadat, L. V. et al. Hepatic Artery Infusion Chemotherapy Compared to Transarterial Radioembolization For Unresectable Colorectal Liver Metastases. Ann. Surg. 10.1097/SLA.0000000000006851 doi:10.1097/SLA.0000000000006851. PubMed Link: https://pubmed.ncbi.nlm.nih.gov/?term=10.1097/SLA.0000000000006851 (Linked via DOI search as the direct PMID is still indexing)Xiao, A. & Fakih, M. KRAS G12C Inhibitors in the Treatment of Metastatic Colorectal Cancer. Clin. Colorectal Cancer 23, 199–206 (2024). PubMed Link: https://pubmed.ncbi.nlm.nih.gov/38825433/André, T. et al. Pembrolizumab in Microsatellite-Instability–High Advanced Colorectal Cancer. N. Engl. J. Med. 383, 2207–2218 (2020). PubMed Link: https://pubmed.ncbi.nlm.nih.gov/33264544/Morris, V. K. et al. Treatment of Metastatic Colorectal Cancer: ASCO Guideline. J. Clin. Oncol. 41, 678–700 (2023). PubMed Link: https://pubmed.ncbi.nlm.nih.gov/36252154/Xu, Z. et al. Treatments for Stage IV Colon Cancer and Overall Survival. J. Surg. Res. 242, 47–54 (2019). PubMed Link: https://pubmed.ncbi.nlm.nih.gov/31071604/Smith, J. J. & D'Angelica, M. I. Surgical Management of Hepatic Metastases of Colorectal Cancer. Hematol. Oncol. Clin. North Am. 29, 61–84 (2015). PubMed Link: https://pubmed.ncbi.nlm.nih.gov/25475573/Strickler, J. H. et al. Tucatinib plus trastuzumab for chemotherapy-refractory, HER2-positive, RAS wild-type unresectable or metastatic colorectal cancer (MOUNTAINEER): a multicentre, open-label, phase 2 study. Lancet Oncol. 24, 496–508 (2023). PubMed Link: https://pubmed.ncbi.nlm.nih.gov/37142372/Kruijssen, D. E. W. van der et al. Upfront resection versus no resection of the primary tumor in patients with synchronous metastatic colorectal cancer: the randomized phase III CAIRO4 study conducted by the Dutch Colorectal Cancer Group and the Danish Colorectal Cancer Group. Ann. Oncol. 35, 769–779 (2024). PubMed Link: https://pubmed.ncbi.nlm.nih.gov/38852675/Hitchcock, K. E., Romesser, P. B. & Miller, E. D. Local Therapies in Advanced Colorectal Cancer. Hematol. Oncol. Clin. North Am. 36, 553–567 (2022). PubMed Link: https://pubmed.ncbi.nlm.nih.gov/35562258/Hitchcock, K. E. et al. Alliance for clinical trials in Oncology (Alliance) trial A022101/NRG-GI009: a pragmatic randomized phase III trial evaluating total ablative therapy for patients with limited metastatic colorectal cancer: evaluating radiation, ablation, and surgery (ERASur). BMC Cancer 24, 201 (2024). PubMed Link: https://pubmed.ncbi.nlm.nih.gov/38350888/Adam, R. et al. Liver transplantation plus chemotherapy versus chemotherapy alone in patients with permanently unresectable colorectal liver metastases (TransMet): results from a multicentre, open-label, prospective, randomised controlled trial. The Lancet 404, 1107–1118 (2024). PubMed Link: https://pubmed.ncbi.nlm.nih.gov/39306468/Elez, E. et al. Encorafenib, Cetuximab, and mFOLFOX6 in BRAF-Mutated Colorectal Cancer. N. Engl. J. Med. 392, 2425–2437 (2025). PubMed Link: https://pubmed.ncbi.nlm.nih.gov/40444708/***Fellowship Application Link: https://forms.gle/QSUrR2GWHDZ1MmWC6Please visit https://behindtheknife.org to access other high-yield surgical education podcasts, videos and more.  If you liked this episode, check out our recent episodes here: https://behindtheknife.org/listenBehind the Knife Premium:General Surgery Oral Board Review Course: https://behindtheknife.org/premium/general-surgery-oral-board-reviewTrauma Surgery Video Atlas: https://behindtheknife.org/premium/trauma-surgery-video-atlasDominate Surgery: A High-Yield Guide to Your Surgery Clerkship: https://behindtheknife.org/premium/dominate-surgery-a-high-yield-guide-to-your-surgery-clerkshipDominate Surgery for APPs: A High-Yield Guide to Your Surgery Rotation: https://behindtheknife.org/premium/dominate-surgery-for-apps-a-high-yield-guide-to-your-surgery-rotationVascular Surgery Oral Board Review Course: https://behindtheknife.org/premium/vascular-surgery-oral-board-audio-reviewColorectal Surgery Oral Board Review Course: https://behindtheknife.org/premium/colorectal-surgery-oral-board-audio-reviewSurgical Oncology Oral Board Review Course: https://behindtheknife.org/premium/surgical-oncology-oral-board-audio-reviewCardiothoracic Oral Board Review Course: https://behindtheknife.org/premium/cardiothoracic-surgery-oral-board-audio-reviewDownload our App:Apple App Store: https://apps.apple.com/us/app/behind-the-knife/id1672420049Android/Google Play: https://play.google.com/store/apps/details?id=com.btk.app&hl=en_US

The conversation revolves around a complex trauma case involving a 26-year-old male who suffered severe injuries from a live round during a training exercise. The discussion covers the patient's initial assessment, the challenges faced during his treatment, the surgical interventions performed, and the lessons learned from the case. The speakers emphasize the importance of timely interventions, effective communication, and the need for continuous improvement in emergency medical practices.TakeawaysThe patient was a 26-year-old male with severe injuries.Initial assessment showed signs of shock despite normal blood pressure.CT scans revealed significant internal bleeding.Surgical interventions were complicated by the patient's deteriorating condition.Massive transfusion protocol was activated due to significant blood loss.Lessons learned include the importance of timely blood product administration.Pre-hospital care plays a crucial role in patient outcomes.Effective communication among medical teams is essential.The case highlights the need for continuous training and preparedness.The patient ultimately required extensive rehabilitation after his injuries.Chapters00:00 Introduction to the Case02:52 Patient Arrival and Initial Assessment06:05 CT Scan and Deterioration08:50 Surgical Interventions and Challenges11:58 Massive Transfusion Protocol and Outcomes14:58 Lessons Learned from the Case18:00 Discussion on Pre-Hospital and In-Hospital Care20:48 Final Thoughts and ReflectionsFor more content, go to ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠www.prolongedfieldcare.org⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Consider supporting us: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠patreon.com/ProlongedFieldCareCollective⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ or ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠www.lobocoffeeco.com/product-page/prolonged-field-care⁠⁠⁠

The advent of newer thrombectomy devices has turned what were once hours-long surgical cutdowns into endovascular cases that last under an hour. In this episode of BackTable, host Dr. Sabeen Dhand is joined by Dr. Shang Loh from the University of Pennsylvania and Dr. Khanjan Nagarsheth from the University of Maryland to discuss the evolution of arterial thrombectomy devices and modern techniques for acute arterial occlusions. --- This podcast is supported by: Inari Medicalhttps://www.inarimedical.com/artix-system --- SYNPOSIS The episode highlights major technological advancements over the past decade, including the development of mechanical and computer-assisted thrombectomy systems. The physicians review key features of newer devices, such as the ability to combine aspiration with stent retrievers, the use of PTFE baskets to reduce distal embolization, and the advantage of maintaining wire access throughout the case. They share strategies for managing specific cases, including acute femoral-popliteal occlusions with distal reconstitution, intraoperative ischemic pain due to flow arrest, trauma-related thrombosis, and cases complicated by extensive calcification and chronic vascular disease. As vascular surgeons, they also discuss the ongoing role of open approaches, outlining when surgical cutdown is indicated and where they prefer endovascular first. The conversation further explores challenges such as acute limb ischemia, stent thrombosis, and visceral artery thrombosis, emphasizing the importance of staying current with rapidly evolving technologies to improve procedural efficiency and patient outcomes. --- TIMESTAMPS 00:00 - Introduction02:04 - Evolution of Arterial Thrombosis Treatment04:11 - New Devices and Techniques10:42 - Case Studies and Practical Applications24:26 - Techniques and Devices for Thrombectomy25:33 - Managing Flow and Patient Safety27:25 - Surgical vs. Endovascular Approaches29:25 - Dealing with Complications and Failures37:50 - Visceral Thrombosis and Advanced Techniques41:09 - Future of Thrombectomy Devices44:27 - Closing Remarks

Featuring an interview with Dr Ravin Ratan, including the following topics: Efficacy and safety of long-term continuous nirogacestat treatment in adults with desmoid tumors: Results from the Phase III DeFi trial (0:00) Onset and resolution of ovarian toxicity with nirogacestat treatment for desmoid tumors: Updated safety analyses from the DeFi trial (4:37) Subgroup analysis of the Phase II part of the RINGSIDE Phase II/III trial of varegacestat for desmoid tumors (7:39) Surgical management of desmoid tumors; cryotherapy in the treatment of extra-abdominal desmoid tumors (10:30) CME information and select publications

An SCP Tale by Veiedhimaedhr: www.scp-wiki.net/surgical-identity-perpetuation License: creativecommons.org/licenses/by-sa/3.0/ ---- The voice of the Database was provided by Joshua Alan Lindsay. The voice of Capt. Ardal Rogers was provided by Bruce Rasnick. The voice of Dr. Joyce Michaels was provided by Oktober Crow. The voice of Darryl Lloyd was provided by Breck Wilhite. ---- Sound Credits "AMBRoom_Commercial Office Hallway Room Tone_PSE_GEN5_j8ArX.wav" by Eric Mooney / PSE "Doors-WoodDoctorsOfficeBath.wav" by SoundStorm / PSE "Gear - movement_walking_01.wav" by SoundMorph / PSE "Modern Office Telephone Plastic Lift KCV1.wav" by Richard King / PSE "NEC Plastic Office Telephone Button Pushes Dial KCV1.wav" by Richard King / PSE "TelephoneSpeaker S08OF.491.wav" by Blastwave FX / PSE ---- Original music by Joshua Alan Lindsay. ---- Enjoy the podcast? Consider supporting us on Patreon! Patrons get access to bonus Joke episodes, outtakes, exclusive merch, and can even request episodes on specific SCP objects. www.patreon.com/thescpfoundationdatabase Listen and read along in one place on our website: www.scpdatapodcast.com/episodes/surgical-identity-perpetuation Follow us on Twitter: twitter.com/SCPDataPodcast Like us on Facebook: www.facebook.com/scpdatapodcast Questions or comments? Email us at SCPDataPodcast@gmail.com

In this episode, Dr. Grace Yum sits down with Dr. Nekky Jamal to discuss practical clinical strategies for extractions, including how to improve healing, reduce post-operative pain, and minimize complications. From the role of platelet-rich fibrin (PRF) to surgical technique and pain management protocols, Dr. Jamal shares actionable insights to help dentists deliver smoother procedures and better patient outcomes. Episode highlights: Using PRF to improve healing and reduce dry socket risk Pain management strategies that minimize opioid use Surgical techniques that reduce trauma and swelling Clinical tools and techniques that support more efficient extractions How communication and case selection help prevent complications Ready to thrive as a dentist and a mom? Join a supportive community of like-minded professionals at Mommy Dentists in Business. Whether you're looking to grow your practice, find balance, or connect with others who understand your journey, MDIB is here to help. Visit mommydibs.com to learn more and become a part of this empowering network today!

Transform how you manage extraction sites and periodontal pockets — get a FREE 30-minute consultation with a specialist + a FREE sample of PerioVive for your practice:

As part of my work at DiepCFoundation, I am able to meet in person, well-known board-certified surgeons across the world. My guest is one such surgeon I know. I have been anxious to interview her. Two words I find myself choosing to describe her are: Adaptable and compassionate. Each time I see her at a conference, the conversation is so easy and comfortable. I can't think it would be any different with her patients. Dr. Andrea Moreira is a plastic surgeon at the University of Pittsburg and Chief of Plastic Surgery at Magee Women's Hospital. Topics she covers in our interview include: ·       How she developed her passion for plastic surgery. ·       The services she provides at Magee Women's Hospital. ·       Dr. Moreira's interest in robotic-assisted DIEP flap. ·       The importance of providing a shared decision-making conversation about sensate breasts with her patients. Connect with Dr. Moreira on the following platform: Instagram: https://www.instagram.com/andrea_moreiramd/

Sponsor: Use code BIRTHHOUR for 20% off your first order and up to 40% off monthly plans at thisisneeded.com. The Birth Hour Links: Know Your Options Online Childbirth Course (code 100OFF for $100 OFF!) Beyond the First Latch Course (comes free with KYO course) Access archived episodes and a private Facebook group via Patreon! Listen to Maureen's first episode 645 via Patreon too!

In this episode of Medsider Radio, we sat down with Massimiliano (Max) Colella, CEO of CMR Surgical.CMR Surgical is developing Versius, a surgical robot designed to make minimally invasive procedures more accessible across specialties.Max brings more than three decades of healthcare leadership experience spanning medtech and hospital systems. He previously held leadership roles at Johnson & Johnson and Smith & Nephew across Europe, Asia Pacific, and the Middle East, and later served as CEO of Evercare Group, a TPG portfolio company.In this interview, Max discusses how to prioritize capital allocation between platform development and product line expansion, when internal processes need restructuring, the importance of having the right culture, and why undertaking market research ahead of launching into a new market is crucial. He also shares his approach to hiring — and on maintaining clear board governance boundaries.Before we dive into the discussion, I wanted to mention a few things:First, if you're into learning from medical device founders and CEOs and want to know when new interviews are live, head over to Medsider.com and sign up for our free newsletter.And if you're ready to level up your medtech game, you should check out Medsider Courses — 8-week masterclasses covering topics like fundraising, M&A and exit planning, design and development, clinical and regulatory strategy, and commercialization.These courses, featuring hard-earned lessons from elite medtech CEOs, can be purchased individually or come free with our All-Access Pass.If you'd rather read than listen, here's a link to the full interview with Max Colella. KEY MOMENTS FROM THE INTERVIEW(03:08) - An overview of Max's background and the journey that led him to CMR Surgical (06:53) - Why Max chose surgical robotics — and how Versius is designed to differentiate from existing systems (16:18) - How Max restructured internal processes at CMR to eliminate large-company bureaucracy (21:09) - How market research reshaped CMR's U.S. strategy beyond ambulatory surgery centers (28:48) - Max's capital allocation philosophy: prioritize system performance and stability before expanding capabilities (32:19) - Max's take on Techmed and the future of robotics (36:36) - Why clearly defined roles between board and management are critical for governance (41:10) - Max's philosophy around hiring for mindset over skill

In this episode of Endo Voices, Dr. Marcus D. Johnson sits down with Dr. Pierre Wohlgemuth for a thoughtful and collegial examination of two defining challenges in contemporary endodontics: the elusive cemental tear and the disciplined art of soft tissue management in surgical care.Cemental tears—seldom discussed yet likely underdiagnosed—often masquerade as endodontic or periodontal pathology. With a limited but growing body of evidence, accurate identification demands clinical vigilance. Key red flags include vital teeth presenting with periapical radiolucencies and persistent disease following technically adequate root canal therapy. The discussion explores the roles of occlusal trauma, CBCT interpretation, and histologic confirmation, reinforcing the importance of expanding the differential diagnosis before defaulting to retreatment or extraction. Decisions surrounding tooth preservation versus implant placement are framed not as reflexive, but as biologically and prognostically driven.A central theme resonates throughout: clinicians do not rise to the level of their intentions—they fall to the level of their training.Episodes of Endo Voices may include opinion, speculation and other statements not verifiable in the scientific method and do not necessarily reflect the views of AAE or the sponsor(s). Listeners should use their best judgment in evaluating the merits of any content.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Season 3, Episode 6 Out Now - Dr Jessica Ryan - Best Practice in Surgical HandoverRCSI is delighted to announce that Episode 6 of our Safe and Sound podcast is OUT NOW featuring Dr Jessica Ryan PhD Candidate RCSI, General Surgery HST, SH-CORE Study Coordinator. With a high number of listeners from across different countries and specialties, Season 3 will again provide a spotlight on key pillars within the ecosystem of Human Factors in Patient Safety.RCSI's latest podcast episode was hosted by Dr Fardod O'Kelly, RCSI Safe and Sound Podcast Host and Senior Lecturer in Surgical Education.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/GGF865. CME/MOC/AAPA/IPCE credit will be available until February 28, 2027.Synchronizing Success in Resectable Gastric/GEJ Cancer: Merging Expertise to Effectively Deliver Immunotherapy Platforms in the Surgical Setting In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an independent educational grant from AstraZeneca.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/GGF865. CME/MOC/AAPA/IPCE credit will be available until February 28, 2027.Synchronizing Success in Resectable Gastric/GEJ Cancer: Merging Expertise to Effectively Deliver Immunotherapy Platforms in the Surgical Setting In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an independent educational grant from AstraZeneca.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/GGF865. CME/MOC/AAPA/IPCE credit will be available until February 28, 2027.Synchronizing Success in Resectable Gastric/GEJ Cancer: Merging Expertise to Effectively Deliver Immunotherapy Platforms in the Surgical Setting In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an independent educational grant from AstraZeneca.Disclosure information is available at the beginning of the video presentation.

In this first edition of the new CTSNet podcast, The Lifeline, host and nurse educator Jill Ley, Clinical Professor at the University of California San Francisco School of Nursing, Founder of the Essentials of Cardiac Surgical Resuscitation, and former Cardiac Surgery Clinical Nurse Specialist at California Pacific Medical Center in San Francisco, CA, USA, speaks with expert guest Barbara McLean, a Critical Care Clinical Nurse Specialist at Grady Memorial Hospital in Atlanta, GA, USA. They discuss end-tidal carbon dioxide (EtCO2) monitoring in cardiac surgical emergencies.  Chapters 00:00 Intro 01:30 End-Tidal CO2 Monitoring Overview 09:16 Case 1 13:52 Case 2 19:57 Outlier Cases 21:01 Global Application Mclean began by providing an overview of EtCO2, including bedside interpretation, values for rapid non-invasive cardiopulmonary evaluation during acute decompensation, critical values that warrant intervention, and how to differentiate ventilation and perfusion abnormalities, metabolic acidosis, hypoventilation, hyperventilation, and arterial CO2. They then discuss various case studies outlining postoperative outcomes and the symptoms patients were experiencing emphasizing this important monitoring modality to aid in accurate and timely clinical assessment during complex emergencies.  Every month, The Lifeline features intensive care specialists sharing their expert insights into the rapid and effective management of critically ill cardiac surgical patients. Don't miss next month's episode!  Disclaimer The information and views presented on CTSNet.org represent the views of the authors and contributors of the material and not of CTSNet. Please review our full disclaimer page here.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/GGF865. CME/MOC/AAPA/IPCE credit will be available until February 28, 2027.Synchronizing Success in Resectable Gastric/GEJ Cancer: Merging Expertise to Effectively Deliver Immunotherapy Platforms in the Surgical Setting In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an independent educational grant from AstraZeneca.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/GGF865. CME/MOC/AAPA/IPCE credit will be available until February 28, 2027.Synchronizing Success in Resectable Gastric/GEJ Cancer: Merging Expertise to Effectively Deliver Immunotherapy Platforms in the Surgical Setting In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an independent educational grant from AstraZeneca.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/GGF865. CME/MOC/AAPA/IPCE credit will be available until February 28, 2027.Synchronizing Success in Resectable Gastric/GEJ Cancer: Merging Expertise to Effectively Deliver Immunotherapy Platforms in the Surgical Setting In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an independent educational grant from AstraZeneca.Disclosure information is available at the beginning of the video presentation.

In this episode, Caroline hosts renowned plastic surgeon and star of Botched, Dr. Terry Dubrow, for a “hard questions” episode and some laughs. He educates us on Ozempic/GLP-1 drugs, microdosing, and newer peptide options like tirzepatide and the not-yet–FDA-approved “retatrutide,” which he says may help lower inflammation and support “preservation longevity” while AI accelerates disease breakthroughs. They discuss fears around AI, his belief that people should learn to use it, and his warning about unregulated online/black-market compounds. In beauty, Dubrow urges women to dial back fillers, avoid “Ozempic face panic,” be cautious with deep plane facelifts, and invest more in consistent energy devices (lasers/ultrasound/radiofrequency) rather than extreme procedures. He shares lessons from Botched and Plastic Surgery Rewind, including turning down risky patients, a memorable case removing “concrete” facial injections by reducing—not fully removing—masses, and how he and his wife test wellness trends on their “Doctor and Mrs. Guinea Pig” channel. He also covers peptides uncertainty, cycling use if someone insists, creatine findings, daily visualization, and marriage rules for handling conflict.Find Dr Dubrow - Website: www.drdubrow.com- Instagram: @drdubrow- TikTok: @drterrydubrow- Botched Presents: Plastic Surgery Rewind on E! and PeacockFollow Caroline:- Podcast: https://being-caroline.com/podcast/- IG: https://www.instagram.com/shop.with.caroline/- TikTok: https://www.tiktok.com/@shop.with.caroline- Facebook: https://www.facebook.com/beingcaroline- Search Looks: https://www.shop-with-caroline.com/- Shop New Merch: https://shop.dearmedia.com/collections/coming-in-hotPlease note that this episode may contain paid endorsements and advertisements for products and services. Individuals on the show may have a direct or indirect financial interest in products or services referred to in this episode.Sponsors:Text HOT to 64000 to get twenty percent off all IQBAR products, plus FREE shipping. Message and data rates may apply.Produced by Dear Media.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

On this week's episode, Brandon Tanguma and Dominic Hobson discuss:LifeMLB NewsWBC Preivew NBA TalkOlympics RecapJRo's ThreesomeTyler's Dumb Facebook QuestionMr. X's Questions of the WeekShoe TalkHave a question? Send it to CurveballandCS@gmail.comFollow us on social media: https://linktr.ee/CurveballsandCS

CardioNerds (Dr. Jenna Skowronski [Heart Failure Council Chair], Dr. Shazli Khan, and Dr. Josh Longinow) are joined by renowned leaders in the field of AHFTC (Advanced Heart Failure and Transplant Cardiology) and mechanical circulatory support, Dr. Jeff Teuteberg and Dr. Mani Daneshmand to continue the discussion of advanced heart failure therapies by taking a deep dive into the world of durable LVADs (Left Ventricular Assist Devices). In this episode, we will review the history of ventricular assist devices, the basics of LVAD function, selection criteria for LVAD therapy, and surgical nuances of LVAD implantation. Audio Editing by CardioNerds intern, Joshua Khorsandi. Enjoy this Circulation 2022 Paths to Discovery article to learn about the CardioNerds story, mission, and values. CardioNerds Heart Success Series PageCardioNerds Episode PageCardioNerds AcademyCardionerds Healy Honor Roll CardioNerds Journal ClubSubscribe to The Heartbeat Newsletter!Check out CardioNerds SWAG!Become a CardioNerds Patron! Pearls There have been significant advances in the field of MCS/LVAD therapy since the first implanted LVAD in the 1960s, to the first FDA approved device in the early 2000's, to now the HM3 LVAD, with the most important change being a centrifugal flow/magnetically levitated design that led to minimized hemocompatibility-related adverse events (HRAE's) (MOMENTUM 3 trial comparing HM2 and HM3).  The REMATCH trial in 2001 was a pivotal trial for LVAD therapy, demonstrating that in a population of patients with advanced HF (70% IV inotrope dependent), LVAD therapy significantly improved survival at both 1 and 2 years as compared to medical therapy alone.    MOMENTUM 3 trial was a landmark trial for the HM3 device, showing that in a population of end stage HF patients (86% inotrope dependent, 32% INTERMACS 1-2, and 60% DT strategy), 5-year survival with HM3 was 58% and HM3 had lower HRAE's compared with HM2.  There are both patient-specific factors and surgical considerations when it comes to candidacy for LVAD therapy.  RV function prior to LVAD is a key determinant for success post-LVAD  Many patients being considered for LVAD may not have robust RV function, however, predicting RV failure after LVAD is exceedingly difficult.   In general, it doesn’t matter how bad the RV may look on imaging; we care more about the pre-LVAD hemodynamics (look at the PAPi and RA/wedge ratio).   What happens in the OR may be the most important determinant of how the RV will do with the LVAD!  Notes Notes drafted by Dr. Josh Longinow.  1. Historical background of heart pumps and LVADs  LVAD Evolution   FDA approval year  2001  2008  2012  2017  Pump  HeartMate XVE   HeartMate II  Heartware HVAD  HeartMate III  Flow/Design Features  Pulsatile Technology   Continuous flow Axial design  Continuous flow  Centrifugal design  Continuous flow   Full MagLev + Centrifugal design  The 1960's ushered in the first ‘LVADs', when the first air-powered ‘LVAD' was implanted. It kept the patient alive for four days before the patient expired.   The first generation of LVADs were pulsatile pumps   The first nationally recognized, FDA approved LVAD was the HeartMate XVE (late 1990s to early 2000s, REMATCH trial). The XVE pump used compressed air (pneumatically driven) to power the pump.   Prior to the XVE, OHT was the standard of care for patients with advanced, end-stage heart failure.   The second and third generations of LVADs were non-pulsatile, continuous flow devices and included the HVAD, HM2, and HM3 devices.   MOMENTUM 3 was a landmark trial for the HM3 device, showing that in a population of sick patients with end stage HF (86% inotrope dependent, 32% INTERMACS 1-2, and 60% DT strategy), 5-year survival with HM3 was 58% and HM3 had lower HRAE's compared with HM2.   The only pump that is currently FDA approved for implant is the HM3, although other pumps are in clinical trials (BrioVAD system, INNOVATE Trial).  2. What are LVADs, and how do they work?   In simplest terms, the LVAD is a heart pump comprised of several key mechanistic components:   Inflow cannula  Mechanical pump   Outflow cannula  Driveline  Controller/Power source  The HM3 differs from its predecessors (HM2 and HVAD) in several key ways;   HM3 is placed intrapericardial whereas the HM2 was placed pre-peritoneal.   Perhaps most importantly, the HM3 is a fully magnetically levitated, centrifugal flow pump, whereas the HM2 is an axial flow device.  Axial flow pumps are not magnetically levitated, leading to more friction produced between the ruby bearing's contact with the pump rotors, and higher rates of hemocompatibility related adverse events (HRAEs, i.e. pump thrombosis) and the HM2 was ultimately discontinued in favor of the HM3 (MOMENTUM 3 trial).  3. What do the terms ‘Destination Therapy' (DT) or ‘Bridge to Transplant' (BTT) mean when it comes to LVADs?   When LVADs first came on the stage, EVERYONE was a BTT; these early pumps weren't designed for long term use (I.e. REMATCH Trial, Heartmate XVE)  Destination therapy means the LVAD was placed in leu of transplant because there are contraindications to transplant   REMATCH trial brought about the concept of “Destination therapy”, comparing outcomes in patients (with contraindications for transplant) who received an LVAD vs optimal medical therapy  Bridge to transplant means we are placing the LVAD in a patient who may not be a transplant candidate at this moment in time (is too sick, or conversely, not sick enough), but may be down the line   Bridge to recovery is another term used when the LVAD is being placed for a patient we think may have a recoverable cardiomyopathy  4. What are some factors we should consider when assessing a patient’s candidacy for LVAD, in general, and from a surgical perspective?   Patient factors   Older age might push us towards thinking LVAD rather than transplant  In general, age > 70 is the cutoff for transplant, but this is not a hard cut off and varies institution to institution    In general, think about things that help predict recovery after a major surgery; Frailty and Nutritional status are important, we try to optimize these prior to LVAD implant   Right ventricular function remains the Achilles heel of LV support  We know that needing temporary RV support post LVAD puts you on a different survival curve than patients who don’t need RVAD support  Studies have not been able to successfully predict who will develop RV failure after LVAD implantation  What happens in the time between when the patient goes to the OR and when they get back to the ICU is an important determinant who might develop RV failure post LVAD   Surgical techniques such as implanting the HM3 in the intra-thoracic cavity, rather than intra-pericardial may help maintain LV/RV geometry to help optimize the RV post LVAD   Surgical considerations for LVAD candidacy  Small, hypertrophied LV: HM3 inflow cannula is small, but small hypertrophied ventricles tend towards chamber collapse during systole causing suction, needing to run slower with lower flow rates  Chest size/diameter: pumps have gotten so small now, that for adults, these have become less of a consideration  BMI: low BMI used to be more of a concern with the older pumps due to where they were placed, and the relative size of the pump itself, not so much now with the smaller HM 3 pumps  Calcified LV apex: would increase risk of stroke, bleeding   Driveline tunneling becomes a concern in the super obese population, higher risk for driveline infections (might tunnel these driveline's shorter, and to a less fatty region of the abdomen, could even tunnel out the thoracic cavity in the super obese to limit skin motion)    5. Is there a role for MCS (i.e. temporary LVAD such as Impella) in pre-habilitation of patients prior to LVAD surgery?   The theory of being able to improve systemic perfusion, decongest the organs, and make the patient feel better prior to surgery makes sense, but becomes problematic due to the lack of a hard end point/time for prehabilitation which might risk delays in surgery   More likely that it can lead to delay in the surgery, with less-than-optimal benefit; you don't want to prolong the wait for surgery and increase the risk for complications prior to surgery    An Impella 5.5 is currently FDA approved for 2 weeks of support, not 2 months so timing is important to keep in mind  It’s unlikely that you will take a patient and convert them from a malnourished, cachectic person in 2 weeks’ time   6. Is there a role for LVAD therapy in the younger patient population? Should we be thinking of LVAD up front for these patients, with the goal of transplanting down the line?   Recovery may be more likely in certain populations, particularly younger females with smaller LV's; in those populations, perhaps bridge to recovery should be the focus, optimizing them on GDMT etc.   The replacement of transplant, with MCS (LVAD) in young patients has become a topic of discussion, because these pumps have become better and better, with the thinking that an LVAD could bridge a patient for 10 years or so, and they could get a transplant later   It is still a big unknown, but several concerns exist  Patients who get LVADs might end up with complications that become contraindication to transplant down the line (stroke, sensitization etc)   Patients and providers are more hesitant because of the more recent iteration for the UNOS criteria for OHT listing which no longer gives patients with an uncomplicated LVAD higher priority, and therefore they could end up waiting a longer time for a heart after undergoing LVAD  References Rose EA, Gelijns AC, Moskowitz AJ, et al. Long-term use of a left ventricular assist device for end-stage heart failure. N Engl J Med. 2001;345(20):1435-1443. doi:10.1056/NEJMoa012175  Mehra MR, Uriel N, Naka Y, et al. A Fully Magnetically Levitated Left Ventricular Assist Device – Final Report. N Engl J Med. 2019;380(17):1618-1627. doi:10.1056/NEJMoa1900486  Mancini D, Colombo PC. Left Ventricular Assist Devices: A Rapidly Evolving Alternative to Transplant. J Am Coll Cardiol. 2015;65(23):2542-2555. doi:10.1016/j.jacc.2015.04.039  Mehra MR, Goldstein DJ, Cleveland JC, et al. Five-Year Outcomes in Patients With Fully Magnetically Levitated vs Axial-Flow Left Ventricular Assist Devices in the MOMENTUM 3 Randomized Trial. JAMA. 2022;328(12):1233-1242. doi:10.1001/jama.2022.16197  Rose EA, Moskowitz AJ, Packer M, et al. The REMATCH trial: rationale, design, and end points. Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart Failure. Ann Thorac Surg. 1999;67(3):723-730. doi:10.1016/s0003-4975(99)00042-9  Kittleson MM, Shah P, Lala A, et al. INTERMACS profiles and outcomes of ambulatory advanced heart failure patients: A report from the REVIVAL Registry. J Heart Lung Transplant. 2020;39(1):16-26. doi:10.1016/j.healun.2019.08.017  Mehra MR, Netuka I, Uriel N, et al. Aspirin and Hemocompatibility Events With a Left Ventricular Assist Device in Advanced Heart Failure: The ARIES-HM3 Randomized Clinical Trial. JAMA. 2023;330(22):2171-2181. doi:10.1001/jama.2023.23204  Mehra MR, Nayak A, Morris AA, et al. Prediction of Survival After Implantation of a Fully Magnetically Levitated Left Ventricular Assist Device. JACC Heart Fail. 2022;10(12):948-959. doi:10.1016/j.jchf.2022.08.002  Bhardwaj A, Salas de Armas IA, Bergeron A, et al. Prehabilitation Maximizing Functional Mobility in Patients With Cardiogenic Shock Supported on Axillary Impella. ASAIO J. 2024;70(8):661-666. doi:10.1097/MAT.0000000000002170 

This week we speak with Dr. John Brown who is the Harris B. Schumacker Professor Emeritus of Surgery at the University of Indiana. A congenital heart surgeon for over 45 years, Dr. Brown has performed more than 15,000 pediatric heart operations at Riley Hospital for Children and another 5000 heart operations in adults at IU and Methodist Hospitals. He performed the first pediatric heart transplant in Indiana and developed the first clinical use of the bovine jugular vein and valve for a pulmonary valve replacment in children. He also performed the only known twin to twin newborn heart transplant in the world. He has done and seen it all and has a unique perspective. How did he achieve so much and still have a succesful 56 year marriage to his wife Carol Ann? What is Dr. Brown most proud of in a career that is as prolific as his? What advice would he have have for the next generation? Prepare to be inspired by this master surgeon and friend and colleague of many in our field.

This Biotech CEO Is Helping Prevent Surgical Infections – Meet Dikla Czaczkes Akselbrad, CEO PolyPid $PYPDGuestDikla Czaczkes Akselbrad, CEO PolyPidCompany PolyPidhttps://www.polypid.com/Ticker: $PYPDDikla's BioMs. Dikla Czaczkes Akselbrad serves as the Chief Executive Officer of PolyPid after serving as the company's EVP and CFO since 2017, leading the company's initial public offering on the Nasdaq Global Market in June 2020. Dikla brings more than 20 years of experience leading life sciences companies through critical international strategic, financial and business transitions, including raising over $350 million in various forms in her prior executive roles. Before joining PolyPid in 2014, Dikla served as CFO of Compugen Ltd. (NASDAQ & TASE: CGEN) after serving as CFO of Packet Technologies Ltd., and an audit manager at Ernst & Young Israel. She received a B.A. in accounting and economics and an MBA from Tel-Aviv University, and is a certified public accountant in Israel.

In this episode, Dr. Osamah Choudhry, Co Founder and CEO of Medivis and neurosurgeon at NYU Langone Health, discusses the evolving role of artificial intelligence and augmented reality in spine and cranial surgery. He shares insights on FDA clearances, distribution strategy, and how next generation navigation technology is improving precision, efficiency, and patient outcomes.

In this episode, Dr. Osamah Choudhry, Co Founder and CEO of Medivis and neurosurgeon at NYU Langone Health, discusses the evolving role of artificial intelligence and augmented reality in spine and cranial surgery. He shares insights on FDA clearances, distribution strategy, and how next generation navigation technology is improving precision, efficiency, and patient outcomes.

Surgical quality is a term that is often thrown around in surgical practice. We have multiple quality improvement projects, metrics and benchmarks that motivate us to do better, and of course the ever expanding patient reviews to possibly “reflect” the type of surgical care provided. But what does quality actually mean? What metrics can we use to understand the type of care being provided by ourselves, our colleagues, and the health system at large. Today, we delve into these questions to understand how quality is currently understood within surgery and how we hope it to evolve in the future. Joining BTK fellow Agnes Premkumar and ASGBI hosts Jared Wohlgemut and Gita Lingam are two fantastic guests - Dr. Mark Cheetham, joining us from the UK, has deep experience in national audits and system-level quality improvement. Dr. Cheetham is a colorectal surgeon and the National Clinical Lead for General Surgery at the Getting it Right First Time Programme in NHS England, or GIRFT. Dr. Alexander Perez is representing the US; he is a board-certified general surgeon and minimally invasive surgeon at Baylor St. Luke's Medical Center. He has worked extensively with institutional quality programs and is the current assistant Dean for patient safety, simulation, and process improvement at the Baylor College of Medicine. Resources: Institute for Healthcare Improvement: https://www.ihi.org/library/tools/quality-improvement-essentials-toolkit NSQIP: https://www.facs.org/quality-programs/data-and-registries/acs-nsqip/ Getting it right first time (UK): https://gettingitrightfirsttime.co.uk/ ***Fellowship Application Link: https://forms.gle/QSUrR2GWHDZ1MmWC6Please visit https://behindtheknife.org to access other high-yield surgical education podcasts, videos and more.  If you liked this episode, check out our recent episodes here: https://behindtheknife.org/listenBehind the Knife Premium:General Surgery Oral Board Review Course: https://behindtheknife.org/premium/general-surgery-oral-board-reviewTrauma Surgery Video Atlas: https://behindtheknife.org/premium/trauma-surgery-video-atlasDominate Surgery: A High-Yield Guide to Your Surgery Clerkship: https://behindtheknife.org/premium/dominate-surgery-a-high-yield-guide-to-your-surgery-clerkshipDominate Surgery for APPs: A High-Yield Guide to Your Surgery Rotation: https://behindtheknife.org/premium/dominate-surgery-for-apps-a-high-yield-guide-to-your-surgery-rotationVascular Surgery Oral Board Review Course: https://behindtheknife.org/premium/vascular-surgery-oral-board-audio-reviewColorectal Surgery Oral Board Review Course: https://behindtheknife.org/premium/colorectal-surgery-oral-board-audio-reviewSurgical Oncology Oral Board Review Course: https://behindtheknife.org/premium/surgical-oncology-oral-board-audio-reviewCardiothoracic Oral Board Review Course: https://behindtheknife.org/premium/cardiothoracic-surgery-oral-board-audio-reviewDownload our App:Apple App Store: https://apps.apple.com/us/app/behind-the-knife/id1672420049Android/Google Play: https://play.google.com/store/apps/details?id=com.btk.app&hl=en_US

Pain can quietly shrink your world—your sleep, your mood, even your sense of future. In Healthy Mind, Healthy Life, hosted by Yusuf, Dr. Christopher Lauria reframes pain as a signal worth listening to, not something to simply silence. This episode is for anyone living with chronic neck, back, or disc discomfort who feels stuck between “meds forever” and “surgery next.” You'll hear how a root-cause approach, patient education, and supportive technologies can help people explore options with more clarity and less fear. About the Guest: Dr. Christopher Lauria is the founder of Roanoke Disc Center and Lifestyle Chiropractic. He has spent nearly three decades helping people address chronic neck, back, and disc pain using non-surgical and integrative approaches. Episode Chapters: 05:20 — Pain as a warning sign, not the enemy 07:58 — Why people assume meds first, surgery last 09:27 — Chronic pain patterns: discs, degeneration, arthritis 11:29 — How pain impacts mood, energy, and relationships 13:02 — Spinal decompression: creating conditions to heal 14:05 — Class 4 laser therapy and tissue support 16:20 — Patience, plateaus, and trusting a longer healing arc Key Takeaways: Treat pain like a “check engine light”: investigate the cause before choosing a path. Ask your provider: “What's the diagnosis—and what's driving it?” Consider a plan that supports healing conditions, not just symptom relief. Expect recovery to take time; relief may come early, healing continues longer. Track mood/energy alongside pain—your nervous system is part of the story. How to Connect With the Guest: Website: https://roanokedisccenter.com/  Email: https://www.podmatch.com/hostdetailpreview/avik Disclaimer: This video is for educational and informational purposes only. The views expressed are the personal opinions of the guest and do not reflect the views of the host or Healthy Mind By Avik™️. We do not intend to harm, defame, or discredit any person, organization, brand, product, country, or profession mentioned. All third-party media used remain the property of their respective owners and are used under fair use for informational purposes. By watching, you acknowledge and accept this disclaimer. Healthy Mind By Avik™️ is a global platform redefining mental health as a necessity, not a luxury. Born during the pandemic, it's become a sanctuary for healing, growth, and mindful living. Hosted by Avik Chakraborty, storyteller, survivor, and wellness advocate. With over 6000+ episodes and 200K+ global listeners, we unite voices, break stigma, and build a world where every story matters.

Transform how you manage extraction sites and periodontal pockets — get a FREE 30-minute consultation with a specialist + a FREE sample of PerioVive for your practice:

Welcome to the Paint The Medical Picture Podcast, created and hosted by Sonal Patel, BA, CPMA, CPC, CMC, ICD-10-CM.Thanks to all of you for making this a Top 15 Medical Billing & Coding Podcast for 5 years on Feedspot.⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Sonal's 17th Season starts up and Episode 4 features Newsworthy updates on the month's fraud, waste, and abuse cases. Sonal's Trusty Tip and compliance recommendations focus on surgical dressings.Spark inspires us all to reflect on beauty, abundance, and innovation based on the inspirational words of Vincent Van Gogh.⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Paint The Medical Picture Podcast now on:Spotify:⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://open.spotify.com/show/6hcJAHHrqNLo9UmKtqRP3X⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Apple Podcasts: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://podcasts.apple.com/us/podcast/paint-the-medical-picture-podcast/id153044217⁠7⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Amazon Music: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://music.amazon.com/podcasts/bc6146d7-3d30-4b73-ae7f-d77d6046fe6a/paint-the-medical-picture-podcas⁠t⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Find Paint The Medical Picture Podcast on YouTube:⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.youtube.com/channel/UCzNUxmYdIU_U8I5hP91Kk7A⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Find Sonal on LinkedIn:⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.linkedin.com/in/sonapate/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠And checkout the website: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://paintthemedicalpicturepodcast.com/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠If you'd like to be a sponsor of the Paint The Medical Picture Podcast series, please contact Sonal directly for pricing: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠PaintTheMedicalPicturePodcast@gmail.com

In this episode, Dr. Christian Péan, CEO and Co Founder of Revel Ai Health and practicing orthopedic trauma surgeon at Duke University School of Medicine, discusses how AI is redefining surgical readiness in ambulatory surgery centers. He explores scalable use cases in patient engagement, quality reporting, interoperability, and how ASC leaders can prepare their data, workflows, and culture for safe AI adoption. This episode is sponsored by Revel Ai.

In this episode, Dr. Christian Péan, CEO and Co Founder of Revel Ai Health and practicing orthopedic trauma surgeon at Duke University School of Medicine, discusses how AI is redefining surgical readiness in ambulatory surgery centers. He explores scalable use cases in patient engagement, quality reporting, interoperability, and how ASC leaders can prepare their data, workflows, and culture for safe AI adoption. This episode is sponsored by Revel Ai.

In this week's episode Ben Blecha and Ané discuss achilles tendinopathies and the role that bracing can play in the recovery from this injury. Ben shares the mechanics of the achilles brace, discussing how the lever arms and forces are applied with a brace, and what we need to look at to have a secure brace that does not slip down the hock. He discusses the role of the foot piece and how hero braces create an articulation with graduated increases in range of motion. We discuss the angle at which the hock is cast or braced during the initial healing phases of the injury, and much more. Learn more about Ben Blecha: https://goherogo.com/ Learn more about MediVet Products: https://medivetproducts.com/ Learn more about on Medivet's blogs: https://medivetproducts.com/blogs/news  Learn more about our free birthday webinars: https://onlinepethealth.com/gift/ Learn more about Paw Prosper's special offer: https://pawprosper.com/OPH Learn more about Paw Prosper: https://pawprosper.com/ To learn about Onlinepethealth, watch a free webinar, or join any of our Facebook groups, click here: https://onlinepethealth.com/podcast

In this episode, Drs. Jason Silverman and Jennifer Lee talk to Dr. Paul Wales all about the surgical management of short bowel syndrome, including decision-making based on initial presentation and important considerations for any autologous reconstruction procedure.Learning objectivesTo define intestinal failure, short bowel syndrome and ultrashort bowel syndrome as well as surgical subtypes of short bowel syndromeTo review surgical considerations in the staged management of short bowel syndromeTo discuss surgical approaches to autologous bowel reconstruction including their potential advantages and disadvantages LinksPapers mentioned:Surgical therapy for short bowel syndrome (review with images)Establishing norms for intestinal length in childrenPredicting Intestinal Adaptation in Pediatric Intestinal FailureAdvantages of the distal sigmoid colostomyDelayed primary STEP procedurePrevious episodes mentioned:Sue Protheroe - Enteral Nutrition in Intestinal FailureDanielle Wendel - Central Line Management in Intestinal Failure (Special JPGN Episode)Ruben Quiros-Tejeira - Multivisceral TransplantationSupport the showThis episode may be eligible for CME credit! Once you have listened to the episode, click this link to claim your credit. Credit is available to NASPGHAN members (if you are not a member, you should probably sign up). And thank you to the NASPGHAN Professional Education Committee for their review!As always, the discussion, views, and recommendations in this podcast are the sole responsibility of the hosts and guests and are subject to change over time with advances in the field.Check out our merch website!Follow us on Bluesky, Twitter, Facebook and Instagram for all the latest news and upcoming episodes.Click here to support the show.

The Challenge of Accessing Courtroom VideoDespite the prevalence of video-equipped courtrooms, Rockind explains that obtaining these recordings has become increasingly difficult.FULL VIDEO: https://youtu.be/uZjpTFD7Kkk?si=m2XlnNJzCULPdhZU#neilrockind #crossexamination #killercrossexamination #legal #attorney #michigan A Shift in Access: In the past, lawyers could often order and pay for copies of courtroom videos for educational or promotional purposes.Current Restrictions: Many court systems now allow individuals to watch the videos at the courthouse but prohibit them from obtaining their own copies.A Rare Glimpse: Zoom Technology in the CourtroomRockind shares a specific instance where he was able to secure a video of his cross-examination due to the use of Zoom technology during the pandemic.The Case: The case involved a client accused of assault with a firearm in a district court.The Technology: The judge used Zoom technology to livestream and record the proceedings, providing multiple camera angles of the judge, witness, and lawyers.Public Access: These videos were subsequently published on YouTube, allowing for broader public viewing and analysis of the cross-examination.Acclaim for Rockind's SkillsThe episode features several positive comments from viewers who have witnessed Rockind's cross-examination techniques:"Surgical" and "Stellar": Viewers praised his precision and professionalism in eliciting necessary facts."Zealous Representation": Many appreciated his dedicated advocacy for his clients, with some even comparing his performance to the legendary Perry Mason.A "Beast" in the Courtroom: His name, Rockind, even garnered praise, with one viewer noting it sounds like a formidable presence in the legal arena.About Neil Rockind - Neil Rockind is a trial lawyer. Neil Rockind is often considered a bet the farm/company type of lawyer, taking on cases where the stakes are “all in.” Neil Rockind appears regularly on television and in the news, defends people in serious court cases, is a regular guest on the Law and Crime Network and also discusses popular trials and cases and current events with other top lawyers around the country. Neil Rockind has won just about every award imaginable, has represented athletes, celebrities, musicians, public figures and has obtained acquittals in all varieties of cases. His nickname is "The Rockweiler" and he's known for his cross examination style.Neil Rockind:Https://www.X.com/neilrockindlawHttps://www.instagram.com/rockindlaw https://www.rockindlaw.com/http://www.killercrossexamination.com/*************************************Subscribe to Killer Cross Examination® PodcastAPPLE: https://podcasts.apple.com/us/podcast...SPOTIFY: https://open.spotify.com/show/424RIys...GOOGLE PODCASTS: https://podcasts.google.com/feed/aHR0...AUDIBLE:https://www.audible.com/pd/Podcast/B0...******************************************Fair Use DoctrineThe contents are under fair use. It may contain copyrighted materials whose use has not been specifically authorized by the copyright owner. This, in our view, is fair use pursuant to section 107 of the US Copyright Law. Fair use allows limited use of copyrighted material without requiring permission from the rights holders, such as for commentary, criticism, news reporting, research, teaching or scholarship. We retain no rights to that material. To the extent the videos capture images or likenesses, we do not own the rights to those images, likenesses, etc and only use them pursuant to the fair use doctrine.All other rights are reserved.

On today's episode, Dr. Dan Brisky and Dr. Tom Pfau dive deep into real-world implant complications and the critical lessons that come with them. From a mispositioned anterior implant that required swallowing pride and starting over, to incision openings in full-arch cases that demanded creative solutions like Botox for excessive muscle activity, they break down what went wrong, how they fixed it, and how to prevent similar issues.  The conversation covers flapless pitfalls, the importance of tactile verification with a ball probe, suture technique nuances, managing tissue dehiscence, preventing bone loss, and even navigating high-stress moments like retrieving displaced root tips and broken burs from the sinus. This candid discussion emphasizes preparation, humility, surgical fundamentals, and having the confidence—and support system—to manage complications the right way. Be sure to check out the full episode from the Dentalpreneur Podcast! EPISODE RESOURCES https://www.coloradosurgicalinstitute.com https://www.truedentalsuccess.com Dental Success Network Subscribe to The Dentalpreneur Podcast

On episode 152 of PSQH: The Podcast, Richard Parker, Associate Director of Physical Environment & Life Safety, Accreditation Commission for Health Care, talks about surgical fire prevention.

Robotic surgery has moved from novelty to norm, and in this episode of Behind the Knife, Drs. James Jung and Joey Lew sit down with urologic pioneer and Medtronic CMO Dr. Jim Porter to dissect how we got here, what the data really say about “the death of laparoscopy,” and where competing robotic platforms like Hugo may take the field next. From ergonomics and education to economics and global access, they tackle both the hype and the hard questions around robotics as the future of minimally invasive surgery.Hosts: ·      James Jung, MD, PhD, Assistant Professor of Surgery, Duke University·      Joey Lew, MD, MFA, Surgical resident PGY-3, Duke University, @lew__actuallyLearning Goals: By the end of this episode, listeners will be able to:·      Describe key clinical, ergonomic, and educational drivers behind the rapid adoption of robotic surgery in the United States and globally.·      Summarize current evidence comparing robotic and laparoscopic approaches for common procedures, including where outcomes are equivalent, inferior, or clearly superior.·      Explain how surgeon ergonomics, trainee experience, and video-based learning influence practice patterns and learning curves in minimally invasive surgery.·      Discuss the role of cost, reimbursement structures, and market competition (e.g., Medtronic Hugo vs da Vinci) in shaping robotic adoption across different health systems.·      Anticipate how next-generation, task- or organ-specific robotic platforms may further change standards of care in minimally invasive surgery.References:·      Violante T, Ferrari D, Novelli M, Larson DW. The Death of Laparoscopy - Volume 2: A Revised Prognosis. A retrospective study. Ann Surg. 2025 Jun 16. doi: 10.1097/SLA.0000000000006792. Epub ahead of print. PMID: 40518997. https://pubmed.ncbi.nlm.nih.gov/40518997/·      Yu Yoshida, Yoshiro Itatani, Takehito Yamamoto, Ryosuke Okamura, Koya Hida, Kazutaka Obama, Single-incision plus one robot-assisted surgery (SIPORS) using the Hugo robotic-assisted surgery (RAS) system for rectal cancer, Annals of Coloproctology, 10.3393/ac.2025.00787.0112, 41, 6, (586-591), (2025). https://pubmed.ncbi.nlm.nih.gov/41486916/Please visit https://behindtheknife.org to access other high-yield surgical education podcasts, videos and more.  If you liked this episode, check out our recent episodes here: https://behindtheknife.org/listenBehind the Knife Premium:General Surgery Oral Board Review Course: https://behindtheknife.org/premium/general-surgery-oral-board-reviewTrauma Surgery Video Atlas: https://behindtheknife.org/premium/trauma-surgery-video-atlasDominate Surgery: A High-Yield Guide to Your Surgery Clerkship: https://behindtheknife.org/premium/dominate-surgery-a-high-yield-guide-to-your-surgery-clerkshipDominate Surgery for APPs: A High-Yield Guide to Your Surgery Rotation: https://behindtheknife.org/premium/dominate-surgery-for-apps-a-high-yield-guide-to-your-surgery-rotationVascular Surgery Oral Board Review Course: https://behindtheknife.org/premium/vascular-surgery-oral-board-audio-reviewColorectal Surgery Oral Board Review Course: https://behindtheknife.org/premium/colorectal-surgery-oral-board-audio-reviewSurgical Oncology Oral Board Review Course: https://behindtheknife.org/premium/surgical-oncology-oral-board-audio-reviewCardiothoracic Oral Board Review Course: https://behindtheknife.org/premium/cardiothoracic-surgery-oral-board-audio-reviewDownload our App:Apple App Store: https://apps.apple.com/us/app/behind-the-knife/id1672420049Android/Google Play: https://play.google.com/store/apps/details?id=com.btk.app&hl=en_US

Fluent Fiction - Norwegian: Courage Under Pressure: A Surgical Story of Friendship and Trust Find the full episode transcript, vocabulary words, and more:fluentfiction.com/no/episode/2026-02-19-08-38-20-no Story Transcript:No: Utenfor Oslo Universitetssykehus blåser den kalde januarluften hardt mot vinduene.En: Outside Oslo Universitetssykehus, the cold January air blows hard against the windows.No: Inne på operasjonsstuen er det stille bortsett fra apparatenes svake pip.En: Inside the operating room, all is quiet except for the faint beeping of the machines.No: Sindre står over operasjonsbordet.En: Sindre stands over the operating table.No: Han snakker seg selv stille.En: He talks quietly to himself.No: "Du klarer dette, Sindre.En: "You can do this, Sindre."No: "Lars, hans nære venn, ligger under hvite laken.En: Lars, his close friend, lies under white sheets.No: En bilulykke har ført ham hit.En: A car accident has brought him here.No: Det haster.En: Time is of the essence.No: Hans liv avhenger av denne operasjonen.En: His life depends on this operation.No: Maren, Sindre sin mentor, står ved siden av.En: Maren, Sindre's mentor, stands beside him.No: Hun ser rolig ut, men øynene hennes følger nøye med på hver bevegelse.En: She looks calm, but her eyes attentively follow every movement.No: "Sindre," sier hun.En: "Sindre," she says.No: "Du kan dette.En: "You know this.No: Husk hva vi har øvd på.En: Remember what we've practiced."No: "Sindre nikker.En: Sindre nods.No: Kunnskapen hans er solid, men i dag er det annerledes.En: His knowledge is solid, but today is different.No: Pasienten betyr noe ekstra for ham.En: The patient means something extra to him.No: Han trekker pusten dypt.En: He takes a deep breath.No: "Jeg er klar," sier han lavt.En: "I'm ready," he says quietly.No: Operasjonen begynner.En: The operation begins.No: Maren gir instruksjoner, og Sindre følger dem nøye.En: Maren gives instructions, and Sindre follows them carefully.No: Han føler presset, tvilen sittende tungt på skuldrene hans.En: He feels the pressure, doubt weighing heavily on his shoulders.No: Tiden går, og alt ser ut til å gå bra.En: Time passes, and everything seems to be going well.No: Men så skjer det — en komplikasjon.En: But then it happens — a complication.No: Blodtrykket til Lars faller plutselig.En: Lars's blood pressure suddenly drops.No: Sindre fryser et øyeblikk.En: Sindre freezes for a moment.No: Øynene hans møter Marens.En: His eyes meet Maren's.No: Hun sier ikke noe, men hennes blikk sier alt.En: She says nothing, but her look says everything.No: Stol på deg selv.En: Trust yourself.No: Sindre fokuserer.En: Sindre focuses.No: Han vet hva han må gjøre.En: He knows what he has to do.No: Med ro til tross for den indre stormen, tar Sindre kontroll.En: With calm despite the internal storm, Sindre takes control.No: Han justerer utstyret, lar håndfuller av kunnskap guide ham.En: He adjusts the equipment, letting his handfuls of knowledge guide him.No: Minutter føles som timer.En: Minutes feel like hours.No: Endelig, blodtrykket stabiliserer seg.En: Finally, the blood pressure stabilizes.No: Et sukk går gjennom rommet.En: A sigh goes through the room.No: Sindre tørker panna, svette blandet med lettelse.En: Sindre wipes his forehead, sweat mixed with relief.No: Operasjonen er ferdig.En: The operation is over.No: Lars er trygg.En: Lars is safe.No: Maren ser på Sindre, et stolende smil over ansiktet hennes.En: Maren looks at Sindre, a proud smile across her face.No: "Godt jobba, Sindre," sier hun.En: "Well done, Sindre," she says.No: Sindre smiler svakt, men denne gangen er det ekte.En: Sindre smiles faintly, but this time it's genuine.No: Han føler lettelsen og stoltheten i brystet.En: He feels the relief and pride in his chest.No: Han har bevist det for seg selv.En: He has proven it to himself.No: Ikke bare har han reddet en venn, men han har også funnet styrken i seg selv.En: Not only has he saved a friend, but he has also found strength within himself.No: Vinden utenfor blåser fortsatt, men inne på operasjonsstuen er det varmt av mestringsfølelse.En: The wind outside still blows, but inside the operating room, it's warm with a sense of achievement. Vocabulary Words:faint: svakebeeping: pipsheets: lakenmentor: mentorcalm: roligattentively: nøyeessence: hasterknowledge: kunnskapencomplication: komplikasjondrops: fallerstabilizes: stabilisereroperation: operasjonenpride: stolthetsense: følelsenachievement: mestringrelief: lettelsedepend: avhengersolid: solidguidelines: instruksjonerpressure: pressetinternal: indrefreezes: fryserknowledge: kunnskapequipment: utstyretgenuine: ekteproven: beviststrength: styrkenstorm: stormenclose: næretrust: stol

Today... Black Canyon Surgical Center is entering its 20th year after a major expansion that boosts capacity and supports rapid growth in staff, surgical volume, and advanced outpatient procedures like robotic-assisted knee replacement. And later... Local artists are hosting the "Art of the Canyon" show and online auction culminating February 28th to raise funds for Black Canyon wildfire restoration projects like re-seeding, invasive species removal, and rebuilding damaged infrastructure.Support the show: https://www.montrosepress.com/site/forms/subscription_services/See omnystudio.com/listener for privacy information.

Naga and the doctors are joined by Becca Rodker to talk about her experience of going through surgical menopause. It's what happens when both ovaries are removed during surgery before you've gone through a natural menopause. It causes the sudden loss of hormones, and it can be very overwhelming. The doctors talk through what happens and answer questions from callers. This episode was first broadcast on BBC 5 Live on 10 February 2026.

Have you longed to integrate your Christian faith into your patient care—on the mission field abroad, in your work in the US, and during your training? Are you not sure how to do this in a caring, ethical, sensitive, and relevant manner? This “working” session will explore the ethical basis for spiritual care and provide you with professional, timely, and proven practical methods to care for the whole person in the clinical setting. https://www.dropbox.com/scl/fi/qpah9kh1lttg6cm1jjop9/Bob-Mason-Ethics-of-Spiritual-Care-revised.pptx?rlkey=0emve2ja8282nv8xc4uinq1hg&st=9033htwx&dl=0

In this episode of Talking Innovation, I interview Michael Compton Jr. about the critical yet often overlooked field of sterile processing in healthcare. We discuss the revolutionary impact of AI on the industry, the importance of the decontamination process, and the challenges faced by sterile processing departments, including workforce shortages and communication failures. The conversation also touches on the potential for outsourcing sterile processing, the significance of water quality standards, and how data analysis can improve surgical outcomes. Michael emphasizes the need for greater recognition and support for sterile processing professionals, highlighting their role in infection prevention and patient safety. I hope you enjoy it!  

Desiree Chappell, Kate Leslie, and Mike Grocott welcome Harriet W. Hopf, a physician-scientist and professor of anesthesiology and adjunct professor of biomedical engineering at the University of Utah, UK. Dr Hopf is known for her leadership in academic governance, medical education, and healthcare research. She shares insights on her distinguished career focusing on surgical site infections and faculty development. We discuss pivotal research on the importance of oxygen in wound healing, mechanisms behind surgical site infections, and the significance of maintaining normothermia during surgery. The conversation also touches on the impact of thermoregulation, volume status, and the use of oxygen in improving patient outcomes. Dr. Hopf emphasizes the necessity of hand hygiene and proper surgical practices to mitigate infections. -- Join us at Evidence Based Perioperative Medicine (EBPOM) World Congress 2026 in London. Be part of a global conversation as clinicians from around the world gather between 7-9th July at the British Library in London. Three days of evidence-based perioperative medicine, global insights, and expert debate—featuring speakers including Michael Marmot and Ken Rockwood. Register here - https://ebpom.org/product/ebpom-world-congress-2026/

In this episode of Modern Chiropractic Mastery, host Dr. Kevin Christie welcomes Dr. Benjamin Fergus to discuss his innovative non-surgical joint replacement technique for knees, shoulders, and hips. Dr. Fergus shares the development of his evidence-based approach, which integrates advanced techniques, shockwave therapy, specific dietary protocols, and structured rehab exercises to address joint degeneration. The episode covers success rates, patient demographics, treatment frameworks, and the importance of combining clinical excellence with effective business practices.

Dr. Chris Stepien — founder of Barefoot Rehabilitation Clinic (Denville, NJ) and developer of Adhesion Release Methods.   Dr. Chris specializes in helping chronic pain sufferers, especially 30–60 year olds who've had pain for 6+ months and have already seen multiple doctors or therapists without real relief. He's also training high-level manual therapists and clinicians to diagnose and treat adhesion and nerve-entrapment patterns so more people can finally get their lives back.   Website: https://www.barefootrehab.com Find a provider: https://www.findanadhesionprovider.com Instagram: @barefootrehab | @adhesionreleasemethods YouTube: @drchrisstepienclips LinkedIn: Dr. Christopher M. Stepien   Become an elitefts channel member for early access to Dave Tate's Table Talk podcast and other perks. @eliteftsofficial   Support Dave Tate's Table Talk:   FULL Crew Access - https://www.elitefts.com/join-the-crew Limited Edition Apparel - https://www.elitefts.com/shop/apparel/limited-edition.html Programs & More - https://www.elitefts.com/shop/dave-tate-s-table-talk-crew.html TYAO Application - https://www.elitefts.com/dave-tate-s-tyao-application   Best-selling elitefts Products: Pro Resistance Training Bands: https://www.elitefts.com/shop/bands.html Specialty Barbells: https://www.elitefts.com/shop/bars-weights/specialty-bars.html Wraps, Straps, Sleeves: https://www.elitefts.com/shop/power-gear.html   Sponsors:   Get an extra 10% OFF at elitefts (CODE: TABLE TALK): https://www.elitefts.com/   Get 10% OFF Your Next Marek Health Labs (CODE: TABLETALK): https://marekhealth.com/tabletalk   Get a free 8-count Sample Pack of LMNT's most popular drink mix flavors: http://www.drinklmnt.com/tabletalk   Support Massenomics! https://www.massenomics.com   Save 20% on monthly, yearly, or lifetime - MASS Research Review (CODE ELITEFTS20): https://massresearchreview.com   RP Hypertrophy App (CODE: TABLE TALK) https://rpstrength.com/pages/hypertrophy-app

You're in the middle of surgical residency, and you realize you need more than a few weeks away from clinical responsibilities. Maybe you need more time to be a parent, recover from an illness, care for family, learn a new skill, or simply create space to reflect and reset. What if you could complete five years of training over six calendar years by spreading that time out in a way that fits your life?  Join Dr. Kara Button with Dr. Joe Buyske, and Dr. Bridget Olson as they break down the 5-in-6 pathway including how it works, who it's for, and the real-world logistics that matter.Hosts:Kara Button, DO — General Surgery Resident, Maine Medical Center; Behind the Knife Surgical Education FellowJo Buyske, MD — President & CEO, American Board of SurgeryDr. Bridget Olsen, MD — General Surgery Resident, Maine Medical CenterReferences: Bamdad MC, Hughes DT, Englesbe M. Safe and supported pregnancy: A call to action for surgery chairs and program directors: A call to action for surgery chairs and program directors. Ann Surg. 2022;275(1):e1-e2. doi:10.1097/SLA.0000000000005181 https://pubmed.ncbi.nlm.nih.gov/34433187/Castillo-Angeles M, Atkinson RB, Easter SR, et al. Pregnancy during surgical training: Are residency programs truly supporting their trainees? J Surg Educ. 2022;79(6):e92-e102. doi:10.1016/j.jsurg.2022.06.011 https://pubmed.ncbi.nlm.nih.gov/35842402/Castillo-Angeles M, Smink DS, Rangel EL. Perspectives of general surgery program directors on paternity leave during surgical training. JAMA Surg. 2022;157(2):105-111. doi:10.1001/jamasurg.2021.6223 https://pubmed.ncbi.nlm.nih.gov/34851404/Kanters AE, Shubeck SP. The importance of parental leave and lactation support for surgeons. Clin Colon Rectal Surg. 2023;36(5):333-337. doi:10.1055/s-0043-1764288 https://pubmed.ncbi.nlm.nih.gov/37564351/Kling SM, Slashinski MJ, Green RL, Taylor GA, Dunham P, Kuo LE. Parental leave experiences for the non-childbearing general surgery resident parent: A qualitative analysis. Surgery. 2024;176(5):1320-1326. doi:10.1016/j.surg.2024.04.035 https://pubmed.ncbi.nlm.nih.gov/38910045/Mann H, Glazer T. Current state of safe pregnancy policies for the US surgical trainee. OTO Open. 2024;8(3):e172. doi:10.1002/oto2.172 https://pubmed.ncbi.nlm.nih.gov/39036338/Rangel EL, Smink DS, Castillo-Angeles M, et al. Pregnancy and motherhood during surgical training. JAMA Surg. 2018;153(7):644-652. doi:10.1001/jamasurg.2018.0153 https://pubmed.ncbi.nlm.nih.gov/29562068/Rangel EL, Castillo-Angeles M, Easter SR, et al. Incidence of infertility and pregnancy complications in US female surgeons. JAMA Surg. 2021;156(10):905-915. doi:10.1001/jamasurg.2021.3301 https://pubmed.ncbi.nlm.nih.gov/34319353/https://www.nytimes.com/2019/12/20/science/doctors-surgery-motherhood-medical-school.htmlhttps://behindtheknife.org/podcast/family-leave-during-surgical-training-a-discussion-with-abs-president-dr-jo-buyskePlease visit https://behindtheknife.org to access other high-yield surgical education podcasts, videos and more.  If you liked this episode, check out our recent episodes here: https://behindtheknife.org/listenBehind the Knife Premium:General Surgery Oral Board Review Course: https://behindtheknife.org/premium/general-surgery-oral-board-reviewTrauma Surgery Video Atlas: https://behindtheknife.org/premium/trauma-surgery-video-atlasDominate Surgery: A High-Yield Guide to Your Surgery Clerkship: https://behindtheknife.org/premium/dominate-surgery-a-high-yield-guide-to-your-surgery-clerkshipDominate Surgery for APPs: A High-Yield Guide to Your Surgery Rotation: https://behindtheknife.org/premium/dominate-surgery-for-apps-a-high-yield-guide-to-your-surgery-rotationVascular Surgery Oral Board Review Course: https://behindtheknife.org/premium/vascular-surgery-oral-board-audio-reviewColorectal Surgery Oral Board Review Course: https://behindtheknife.org/premium/colorectal-surgery-oral-board-audio-reviewSurgical Oncology Oral Board Review Course: https://behindtheknife.org/premium/surgical-oncology-oral-board-audio-reviewCardiothoracic Oral Board Review Course: https://behindtheknife.org/premium/cardiothoracic-surgery-oral-board-audio-reviewDownload our App:Apple App Store: https://apps.apple.com/us/app/behind-the-knife/id1672420049Android/Google Play: https://play.google.com/store/apps/details?id=com.btk.app&hl=en_US